Disclosures for "Long-term Follow-up of Multiple Sclerosis Patients Treated With Cladribine Tablets as De-escalation Strategy From AntiCD20"
-
Dr. Gobbi has nothing to disclose.
-
Author has nothing to disclose
-
The institution of Dr. Disanto has received research support from Swiss MS Sociery.
-
Dr. Mallucci has nothing to disclose.
-
Dr. Masciullo has nothing to disclose.
-
Aleksandra Maceski has nothing to disclose.
-
Dr. Kuhle has nothing to disclose.
-
The institution of Dr. Zecca has received research support from Ente Ospedaliero Cantonale.